Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivaracetam for partial-onset seizures
2006-006345-14Phase 3
- Sponsor
- UCB
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of brivaracetam in epilepsy and Focal Onset Epilepsy (4 arms), sponsored by UCB. Primary endpoint: Partial onset seizure frequency per week.
02
Drugs
brivaracetam
03
Conditions
epilepsyFocal Onset Epilepsy
Beyond the preview
Go deeper on 2006-006345-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006345-14.